UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 895

Sortiert nach

Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2013-01, Vol.24 (1), p.220-225

2013

Link zum Volltext

Verfügbarkeit prüfen

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

Annals of oncology, 2004-08, Vol.15 (8), p.1179-1186

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Annals of oncology, 2016-02, Vol.27 (2), p.318-323

2016

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer

Annals of oncology, 2003-04, Vol.14 (4), p.564-569

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma

Annals of oncology, 2015-07, Vol.26 (7), p.1476-1480

2015

Link zum Volltext

Verfügbarkeit prüfen

Concomitant Chemoradiotherapy as Primary Therapy for Locoregionally Advanced Head and Neck Cancer

Journal of clinical oncology, 2000-04, Vol.18 (8), p.1652-1661

2000

Link zum Volltext

Verfügbarkeit prüfen

Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary

Annals of oncology, 2003-08, Vol.14 (8), p.1306-1311

2003

Link zum Volltext

Verfügbarkeit prüfen

Concomitant Infusional Paclitaxel and Fluorouracil, Oral Hydroxyurea, and Hyperfractionated Radiation for Locally Advanced Squamous Head and Neck Cancer

Journal of clinical oncology, 2001-04, Vol.19 (7), p.1961-1969

2001

Link zum Volltext

Verfügbarkeit prüfen

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

Annals of oncology, 2019-03, Vol.30 (3), p.471-477

2019

Link zum Volltext

Verfügbarkeit prüfen

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

The New England journal of medicine, 1992-12, Vol.327 (23), p.1618-1624

1992

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2715-2721

1998

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2004-08, Vol.45 (2), p.243-253

2004

Link zum Volltext

Verfügbarkeit prüfen

The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer

Seminars in oncology, 2000-08, Vol.27 (4 Suppl 8), p.34

2000

Link zum Volltext

Verfügbarkeit prüfen

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer

Annals of oncology, 2001-03, Vol.12 (3), p.343-347

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer

Journal of clinical oncology, 1996-05, Vol.14 (5), p.1663-1671

1996

Link zum Volltext

Verfügbarkeit prüfen

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

Journal of clinical oncology, 1994-02, Vol.12 (2), p.385-395

1994

Link zum Volltext

Verfügbarkeit prüfen

NCCN Practice Guidelines for Head and Neck Cancers

Oncology (Williston Park, N.Y.), 2000-11, Vol.14 (11A), p.163

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer

Clinical cancer research, 1995-09, Vol.1 (9), p.973-979

1995

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer

The cancer journal (Sudbury, Mass.), 2001-03, Vol.7 (2), p.140

2001

Link zum Volltext

Verfügbarkeit prüfen

Lymphoepithelioma-Like Carcinoma of the Lung

The Annals of thoracic surgery, 1997-10, Vol.64 (4), p.1162-1164

1997

Link zum Volltext

Verfügbarkeit prüfen

High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer

Bone marrow transplantation (Basingstoke), 1997-11, Vol.20 (9), p.721-729

1997

Link zum Volltext

Verfügbarkeit prüfen

Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study

Journal of clinical oncology, 1987-04, Vol.5 (4), p.592-600

1987

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck a long term analysis for the Illinois Cancer Center

Cancer, 1997-02, Vol.79 (3), p.588-594

1997

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9

Head & neck, 2000-07, Vol.22 (4), p.328-335

2000

Link zum Volltext

Verfügbarkeit prüfen

Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management

Current opinion in oncology, 2001-05, Vol.13 (3), p.176-182

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 895

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(737)
Mit Volltextzugriff
(741)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(482)
Life Sciences & Biomedicine
(415)
Humans
(321)
Male
(227)
Female
(195)
Adult
(168)
Biological And Medical Sciences
(168)
Middle Aged
(160)
Animals
(148)
Medical Sciences
(135)
Aged
(134)
Oncology
(120)
Guinea Pigs
(79)
Treatment Outcome
(57)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(54)
Pharmacology. Drug Treatments
(54)
Aged, 80 And Over
(48)
Combined Modality Therapy
(48)
Cardiovascular System & Cardiology
(45)
Tumors
(45)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer

Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma

Concomitant Chemoradiotherapy as Primary Therapy for Locoregionally Advanced Head and Neck Cancer

Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary

Concomitant Infusional Paclitaxel and Fluorouracil, Oral Hydroxyurea, and Hyperfractionated Radiation for Locally Advanced Squamous Head and Neck Cancer

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival

A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer

The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer

Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

NCCN Practice Guidelines for Head and Neck Cancers

Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer

Lymphoepithelioma-Like Carcinoma of the Lung

High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer

Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck a long term analysis for the Illinois Cancer Center

Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9

Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management

Suchergebnisse filtern